In 1,910 intermediate-risk patients with severe aortic stenosis in the PARTNER 2A trial, 10-year mortality was 86.1% after balloon-expandable TAVR vs 82.8% after surgery (HR 1.13; 95% CI 1.02-1.25), mainly in non-transfemoral access; reintervention 6.3% vs 1.6%.
RCTn = 1,910
Thourani et al. 10-Year Randomized Outcomes of Transcatheter or Surgical Aortic Valve Replacement in Intermediate-Risk Aortic Stenosis